Apollo Endosurgery, Inc. Quarterly Depreciation in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Apollo Endosurgery, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q4 2022.
  • Apollo Endosurgery, Inc. Depreciation for the quarter ending December 31, 2022 was $326K, a 14.8% increase year-over-year.
  • Apollo Endosurgery, Inc. Depreciation for the twelve months ending December 31, 2022 was $1.21M, a 10.8% decline year-over-year.
  • Apollo Endosurgery, Inc. annual Depreciation for 2022 was $1.21M, a 10.8% decline from 2021.
  • Apollo Endosurgery, Inc. annual Depreciation for 2021 was $1.36M, a 23.8% decline from 2020.
  • Apollo Endosurgery, Inc. annual Depreciation for 2020 was $1.78M, a 4.3% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $1.21M $326K +$42K +14.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $1.17M $316K +$31K +10.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $1.14M $283K -$74K -20.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $1.21M $284K -$145K -33.8% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $1.36M $284K -$149K -34.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.5M $285K -$150K -34.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $1.65M $357K -$96K -21.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $1.75M $429K -$29K -6.33% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $1.78M $433K -$15K -3.35% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-22
Q3 2020 $1.79M $435K -$1K -0.23% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $1.8M $453K -$19K -4.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $1.81M $458K -$45K -8.95% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $1.86M $448K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $436K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $472K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $503K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.